Answers are grounded in this paper and cite their sources.
Orthodontic tooth movement is a biologically regulated process involving coordinated remodeling of the periodontal ligament and alveolar bone in response to mechanical loading. Although conventional orthodontic mechanics remain the principal means of controlling tooth movement, pharmacological modulation of bone remodeling has emerged as a potential adjunct for accelerating tooth movement, enhancing anchorage, reducing relapse, and managing treatment-related complications. Increasing understanding of the receptor activator of nuclear factor-kappa B ligand/receptor activator of nuclear factor-kappa B/osteoprotegerin (RANKL/RANK/OPG) axis, prostaglandin signaling, osteogenic pathways, inflammatory mediators, and cellular mechanotransduction has provided opportunities for targeted pharmacological intervention. This review critically examines recent advances in drug-based modulation of orthodontic tooth movement, with particular emphasis on the transition from systemic pharmacological exposure toward localized and controlled drug-delivery strategies. Evidence concerning non-steroidal anti-inflammatory drugs, corticosteroids, bisphosphonates, vitamin D, parathyroid hormone, prostaglandins, statins, osteoprotegerin/RANKL-related approaches, growth factors, and emerging molecular targets is discussed. Particular attention is given to local delivery systems including liposomes, sustained-release formulations, biomaterial-based carriers, microneedle systems, and targeted biological delivery. Recent experimental evidence demonstrates that local delivery of biological molecules can alter osteoclastogenesis and tooth movement while potentially reducing systemic exposure. However, most emerging approaches remain supported predominantly by animal or preclinical evidence, and questions concerning dose, delivery route, tissue specificity, safety, and long-term effects remain unresolved. The future of pharmacological modulation in orthodontics is likely to depend less on systemic administration of conventional drugs and more on precise, site-specific delivery of biologically active agents. Such strategies may permit controlled modification of alveolar bone remodeling while minimizing unwanted systemic effects. Translational research integrating drug-delivery technology with orthodontic biomechanics may therefore provide a foundation for personalized pharmacological adjuncts to orthodontic treatment.
No takes yet. Share an insight, caveat, or question.
Ajmera et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: